Hypodontia Market Research Report – Global Forecast till 2030

Hypodontia Market Research Report – By Causes (Hormonal Defects, Infection, Genetics, Environmental), Treatment (Paediatric Dentistry Restorative Dentistry, Orthodontics, Oral Surgery), End Users (Hospital & Clinics, Dental Centers) - Global Forecast till 2030

ID: MRFR/MED/3609-HCR | 90 Pages | Published By Rahul Gotadki on March 2023         

Hypodontia Market Speak to Analyst Request a Free Sample

Hypodontia Market Scenario

The hypodontia market is anticipated to reach USD 4029.5 Million by 2030 at 6.2% CAGR during the forecast period 2022-2030.Hypodontia is the non-formation of one or more teeth during the developmental period. The exact cause of the condition  remains unknown, however some of the possible causes are expected to be hormonal, genetic, infection and environmental factors. The condition is more common in females than in males, with a 3:2 ratio. The hypodontia market growth is majorly attributed to the increasing prevalence of dental diseases, growing dental procedures, increasing funding, and healthcare insurance coverage. According to the Pew Center on the States, in 2010, Americans spend USD 106 billion on dental care. Additionally, according to the American Dental Association, in 2014, over 52.3% of adults reported to visit the dentist every six months, 15.4% reported once per year, and 11.0% reported once every two to three years. According to the American Dental Association, in 2010, over 600 million dental procedures were performed which is expected to increase in coming future. Increasing prevalence of the disease resulting in huge opportunity for the development of the market is driving many manufacturers to focus on developing new and better products for the treatment. Advancing technology in dentistry is adding fuel to the growth of the market. However, the treatments available in the market are expensive and are not affordable for the people in developing regions. Thus, high cost of the treatment may slow the Hypodontia Market growth during the forecast period.

Intended Audience

  • Pharmaceutical companies

  • Biotechnological institutes

  • Government and Private Laboratories

  • Research and Development (R&D) Companies

  • Medical Research Laboratories

  • Market Research and Consulting Service Providers 

Figure 1:- Hypodontia market share, by region  Hypodontia Market

Sources: WHO, annual reports, press release, white paper, and company presentation


The hypodontia market is segmented on the basis of causes, treatment, and end users.

On the basis of the causes, the market is segmented into hormonal defects, infection, genetics, environmental, and others. Hormonal defects is further segmented into idiopathic hypoparathyroidism and pseudohypoparathyroidism. Infection is further segmented into rubella, candida, and others. Genetics is sub segmented into MSX1 and PAX9.

On the basis of the treatment, the market is segmented into paediatric dentistry, restorative dentistry, orthodontics, oral surgery, and others.

On the basis of the end users, the market is segmented into hospital & clinics, dental centers, and others. 

Regional Analysis

The Americas dominate the hypodontia market owing to a well-developed healthcare sector and a huge patient population. According to findings from the Centers for Disease Control and Prevention, (2012), one out of every two American adult aged 30 and over has periodontal disease. Additionally, according to findings from the Centers for Disease Control and Prevention in 2012, approximately 91 % of US adults aged 20–64 had dental caries in permanent teeth. Increasing government support for research & development has supported the hypodontia market growth. Furthermore, increased R&D activities and the concentration of major companies have fuelled the growth of the market in this region.

Europe accounts for the second largest hypodontia market, which is followed by Asia Pacific. Availability of funds for research, huge patient population and strong government support for research & development have driven the market growth. During last decade, there is a significant increase in the number of patients suffering from the hypodontia which has boosted the market growth. For instance, countries like Germany and France are increasing their investment in the healthcare domain which is providing a base for the growth of the market. 

Asia Pacific is the fastest growing region for the market owing to the presence of a huge patient population suffering from dental diseases, continuously developing economies, and presence of huge opportunity in the market. The government in this region is encouraging the manufactures, which is likely to provide a push to the growth of the market.

On the other hand, the Middle East & Africa has the least share in the hypodontia market due to presence of poor economy especially in African region. Majority of the market in this region is held by the Middle East due to a well-developed healthcare sector and huge healthcare expenditure. 

Research Methodology Global Hypodontia Market

Sources: WHO, annual reports, press release, white paper, and company presentation 

Key players for hypodontia market

The key players for the hypodontia  market are Patterson Dental (U.S.), Henry Schein (U.S.), Dentsply Sirona (U.S.), 3M (U.S.), Pfizer (U.S), Bayer AG (Germany), Straumann (Switzerland), Danaher Corporation (Switzerland), PLANMECA OY (Finland), Carestream Health, Inc. (U.S),  Biolase Inc (U.S), KERR Corporation (U.S), GC orthodontics (Germany),, and American Orthodontics (U.S).

Speak to Analyst Ask for Customization